Install
Inside Precision Medicine is the only global media brand covering the full spectrum of precision medicine, taking a wide lens approach while bringing into sharp focus the many complex and interconnected issues that constitute the field.
- 58articles · 30d
- 3+ day agolatest article
- Aug 17, 2026earliest in window
- 98%with images
- 345avg words
- Health & Wellness 56
- Medical 55
- Health 50
- Science & Technology 8
- Science & Nature 3
- People & Society 1
- STEM 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Riaan’s Therapeutic Odyssey – Chapter 2: The Researchers
3+ day, 20+ hour ago (641+ words) By Jonathan D. Grinstein, PhD Could an academic laboratory build genetic medicines for diseases the traditional drug-development model leaves behind? Sena-Esteves sees that mismatch repeatedly. “I wish it wasn’t that way—that we had plenty of money and could just work…...
Starch Reality: Gene Therapy Gives GSD1a Patients a Metabolic Safety Net
1+ week, 5+ day ago (1065+ words) Ultragenyx's FDA-approved gene therapy for glycogen storage disease type Ia (GSD1a), Genglycos, may prevent deadly hypoglycemia for patients with specific genotypes By Jonathan D. Grinstein, PhD The consequence has been a never-ending spell of anxiety and exhaustion. “We’ve never slept through the…...
Ken Greenberg: Can Ultrasound Shatter the Gene Therapy Delivery Bottleneck?
2+ week, 5+ day ago (1169+ words) SonoThera's founder and CEO says ultrasound could overcome genetic medicine's biggest delivery challenges, including payload size, tissue targeting, and repeat dosing By Jonathan D. Grinstein, PhD The potential is enormous because targeting is driven largely by physics rather than a biological…...
Ultragenyx Receives Accelerated FDA Approval For Metabolic Gene Therapy
3+ week, 3+ day ago (225+ words) Rare disease specialist Ultragenyx’s gene therapy Genglycos has received accelerated approval from the FDA for treatment of glycogen storage disease type Ia (GSDIa), a rare metabolic condition. This marks the fifth FDA approval for the California-based biotech, which has already…...
Gene Therapy Could Reverse Genetic Heart Disease, Spare Children from Transplants
3+ week, 6+ day ago (481+ words) Researchers in Australia have developed a gene therapy that could restore heart function in children born with mutations that cause cardiomyopathy. A study published in Nature Cardiovascular Research suggests this approach could potentially address more than 25% of cardiomyopathies that have…...